Xenotransplantation - Nuffield Council on Bioethics
Xenotransplantation - Nuffield Council on Bioethics
Xenotransplantation - Nuffield Council on Bioethics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Animal-to-Human Transplants : the ethics of xenotransplantati<strong>on</strong><br />
Advisory Committee <strong>on</strong> <str<strong>on</strong>g>Xenotransplantati<strong>on</strong></str<strong>on</strong>g><br />
10.31 Implementing the precauti<strong>on</strong>s outlined above will require an expert and authoritative<br />
body that is independent of the research teams at work <strong>on</strong> xenotransplantati<strong>on</strong>. In<br />
view of the seriousness of the issues and of the public c<strong>on</strong>cerns about the technique,<br />
the Working Party recommends that the Department of Health should<br />
establish an Advisory Committee <strong>on</strong> <str<strong>on</strong>g>Xenotransplantati<strong>on</strong></str<strong>on</strong>g>. The proposed<br />
Advisory Committee <strong>on</strong> <str<strong>on</strong>g>Xenotransplantati<strong>on</strong></str<strong>on</strong>g> should combine the necessary scientific<br />
and medical expertise to examine early protocols with broader expertise to ensure<br />
that the Committee keeps in mind the wide range of issues raised by xenotransplantati<strong>on</strong>.<br />
It should be open and accountable. There would be a need for close<br />
liais<strong>on</strong> between the proposed Advisory Committee and the Animal Procedures<br />
Committee (paragraphs 6.38 - 6.41).<br />
Early patients<br />
10.32 Xenotransplants should be offered to human patients <strong>on</strong>ly when results using animal<br />
recipients suggest that these operati<strong>on</strong>s will have a reas<strong>on</strong>able chance of success.<br />
There is currently little c<strong>on</strong>sensus within the transplantati<strong>on</strong> community, both in<br />
the UK and in the US, as to whether the current data using animal recipients justifies<br />
progressing to clinical trials. The Working Party recommends that no<br />
xenotransplantati<strong>on</strong> trials involving human recipients should proceed until<br />
the proposed Advisory Committee <strong>on</strong> <str<strong>on</strong>g>Xenotransplantati<strong>on</strong></str<strong>on</strong>g> is in place and<br />
has approved the trials (paragraphs 7.2 - 7.8). The restricti<strong>on</strong> of xenotransplantati<strong>on</strong><br />
to a small number of centres would allow effective c<strong>on</strong>trol of the risks associated<br />
with the potential transmissi<strong>on</strong> of infectious diseases and careful protecti<strong>on</strong> of early<br />
patients (paragraph 7.34).<br />
10.33 Local Research Ethics Committees (LRECs) review, and must approve, all proposals<br />
for research involving human participants. All proposals for clinical trials of<br />
xenotransplantati<strong>on</strong> will require LREC approval, in additi<strong>on</strong> to the approval of the<br />
proposed Advisory Committee <strong>on</strong> <str<strong>on</strong>g>Xenotransplantati<strong>on</strong></str<strong>on</strong>g> (paragraph 7.9).<br />
10.34 Even when the results from animal experiments suggest that xenotransplantati<strong>on</strong><br />
involving human recipients is justifiable, the early clinical trials will involve unknown<br />
and unpredictable risks. The questi<strong>on</strong> then becomes how best to protect early<br />
patients’ welfare and interests. It is of the utmost importance that potential patients<br />
give free and properly informed c<strong>on</strong>sent to participati<strong>on</strong> in the first xenotransplantati<strong>on</strong><br />
trials. The Working Party recommends that the c<strong>on</strong>sent of patients to<br />
participati<strong>on</strong> in xenotransplantati<strong>on</strong> trials is sought by appropriately<br />
trained professi<strong>on</strong>als who are independent of the xenotransplantati<strong>on</strong><br />
team. The informati<strong>on</strong> given to prospective recipients should include an<br />
estimati<strong>on</strong> of likely success, attendant risks and subsequent quality of life<br />
(paragraphs 7.14 - 7.18).<br />
118